You just read:

Sangamo Therapeutics Announces Presentation of New Data Demonstrating Significant Reduction of Tau Expression Using Proprietary ZFP Gene Regulation Technology

News provided by

Sangamo Therapeutics, Inc.

Mar 29, 2017, 07:30 ET